- Works count
- 1,025
- Citation count
- 56,911
- H-index
- 88
- i10-index
- 349
Research interests
Publications
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
The Lancet · 2018 · 10.1016/s0140-6736(18)30207-1
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · 10.1093/annonc/mdt303
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
New England Journal of Medicine · 2013 · 10.1056/nejmoa1305275
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.27.4860
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine · 2006 · 10.1056/nejmoa053422
Current projects
No projects listed.